Evidence map›Paper›PMID 37171636›Full record

ArticleActa neuropathologica2023

Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas.

Justin Z Wang, Vikas Patil, Jeff Liu, Helin Dogan, Ghazaleh Tabatabai, Leeor S Yefet, Felix Behling, Elgin Hoffman, Severa Bunda, Rebecca Yakubov and 14 more

Open access · hybridAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta neuropathologica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 13 institutions in 4 countries.

Justin Z WangMacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada.
Vikas PatilMacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada.
Jeff LiuMacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada.
Helin DoganDepartment of Neuropathology, University Hospital Heidelberg (DKFZ), Heidelberg, Germany.
Ghazaleh TabatabaiGerman Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, Tübingen, Germany.
Leeor S YefetDivision of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.
Felix BehlingDepartment of Neurosurgery, Center for Neuro-Oncology, Comprehensive Cancer Center, Eberhard Karls University Tübingen, Tübingen, Germany.
Elgin HoffmanCluster of Excellence (EXC 2180) "Image Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University Tübingen, Tübingen, Germany.
Severa BundaMacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada.
Rebecca YakubovMacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada.
Ramneet KalotiMacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada.
Sebastian BrandnerDivision of Neuropathology, UCL Queen Square Institute of Neurology, London, UK.
Andrew GaoDivision of Laboratory Medicine and Pathobiology, University Health Network, Toronto, ON, Canada.
Aaron Cohen-GadolDepartment of Neurosurgery, Indiana University, Bloomington, IND, USA.
Jill Barnholtz-SloanDivision of Cancer Epidemiology and Genetics, Center for Biomedical Informatics and Information Technology, National Cancer Institute, National Institutes of Health, Gaithersburg, MD, USA.
Marco SkardellyDepartment of Neurology and Interdisciplinary Neuro-Oncology, Center for Neuro-Oncology, Comprehensive Cancer Center, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Tübingen, Germany.
Marcos TatagibaDepartment of Neurosurgery, Center for Neuro-Oncology, Comprehensive Cancer Center, Eberhard Karls University Tübingen, Tübingen, Germany.
David R RaleighDepartment of Radiation Oncology, Neurological Surgery, and Pathology, University of California San Francisco, San Francisco, CA, USA.
Felix SahmDepartment of Neuropathology, University Hospital Heidelberg (DKFZ), Heidelberg, Germany.
Paul C BoutrosDepartment of Human Genetics, University of California Los Angeles (UCLA), Los Angeles, CA, USA.
Kenneth AldapeLaboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
International Consortium on Meningiomas (ICOM)
Farshad NassiriMacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada. farshad.nassiri@mail.utoronto.ca.
Gelareh ZadehMacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada. gelareh.zadeh@uhn.ca.
University of Toronto · CAUniversity Health Network · CAHertie Institute for Clinical Brain Research · DEUniversity Hospital Heidelberg · DEUniversity of Tübingen · DEBernstein Center for Computational Neuroscience Tübingen · DEIndiana University Bloomington · USNational Cancer Institute · USNational Institutes of Health · USPrincess Margaret Cancer Centre · CAUniversity College London · GBUniversity of California, Los Angeles · USUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37171636
PMCPMC10261159
OpenAlexW4376223938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.